India licenses generic copy of patented Bayer drug – Pittsburgh Tribune-Review

March 13, 2012 Posted By: Leave a comment
India effectively ended Bayer AG's monopoly on a patented cancer drug on Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable. India's patent office approved Natco Pharma Ltd.'s application to produce the kidney and ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>